Giuseppe Murdaca Dr.
PhD in Science and Space Engineering at the University of Genova (Italy) · Italy
Editorial leadership for Journal of Human Health Research ISSN 2576-9383
Research interests
- Immunodeficiency
- Autoimmunity
- Neuro-Endocrino-Immunology
- Pharmacogenomics
Biography
Prof Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy). Based on this research and fellowship training he has received several awards and honors, such as: Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Selected publications
- Borro M, Murdaca G, Negrini S, Long A, Chinthrajah S. H2-Antagonist in IgE-Mediated Type I Hypersensitivity Reactions. J Allergy Ther. 2020;11: 292. (IF: 1.762).
- Carbone RG, Murdaca G, Negrini S, Penna D, Puppo F. Diagnosis of an unusual case of idiopathic mediastinal fibrosis by 18F-FDG PET/CT. Radiology Case Reports 2020;15(4):435-6. (IF: 0.430).
- Negrini S, Contini P, Pupo F, Greco M, Murdaca G, Puppo F. Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus. Hum Immunol. 2019 in press. (IF: 2.202).
- Murdaca G, Greco M, Tonacci A, Negrini S, Borro M, Puppo F, Gangemi S. IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases. Int J Mol Sci. 2019;20(23): E5856. (IF: 4.183).
- Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models. Int J Mol Sci. 2019;20(16): pii: E3938. (IF: 4.183).
Considering JHHR for your work?
This journal is guided by Giuseppe Murdaca (PhD in Science and Space Engineering at the University of Genova (Italy)) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.